Global Blood Screening Market Size Projected to Reach $5.33 Billion During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Blood Screening Market Over The Five-Year Period 2025–2029?

The blood screening market size has shown robust growth in recent years. It is anticipated to expand from $3.15 billion in 2024 to $3.44 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.4%. This historical growth can be linked to heightened requirements for blood transfusions, an increasing prevalence of transmissible illnesses, existing government regulations and standards, a rise in blood donations and collection efforts, alongside global health concerns and pandemics.

The blood screening market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $5.33 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.5%. This projected growth during the forecast period is primarily driven by factors such as enhanced healthcare infrastructure, widespread public health awareness initiatives, breakthroughs in infectious disease diagnostics, escalating global health issues, and strategies for pandemic readiness. Key trends anticipated within this period encompass an increase in infectious diseases, greater emphasis on automation and operational efficiency, growing demands for blood transfusions, a heightened focus on transfusion safety, and continued research into pathogen detection methods.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

Which Drivers Are Shaping The Blood Screening Industry’s Market Share?

The rising occurrence of infectious diseases is anticipated to drive the expansion of the blood screening market in the future. Blood analysis frequently involves detecting specific antibodies produced in response to infectious agents, thereby assisting healthcare professionals in managing infectious diseases, limiting patient infection transmission, and curbing person-to-person spread. For example, data from June 2022 by the National Center for Biotechnology Information, a US-based government agency, shows that over two decades, the incidence of infectious diseases in outpatient settings nearly tripled, rising from 8 to 26 per 1,000. Consequently, the escalation in the prevalence of infectious diseases is fueling the development of the blood screening market.

How Is The Blood Screening Market Segmented?

The blood screeningmarket covered in this report is segmented –

1) By Product: Reagents And Kits; Instruments; Software And Services

2) By Technology: Nucleic Acid Testing; Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Tests; Western Blot Assays; Next-Generation Sequencing (NGS)

3) By End User: Blood Banks; Diagnostic Centers And Pathology Labs; Hospitals; Clinics; Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents; Testing Kits

2) By Instruments: Automated Analyzers; Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS); Data Analysis Software; Support And Consulting Services

Which Ongoing Trends Are Expected To Shape The Blood Screening Market Outlook?

Leading companies in the blood screening market are developing technologies such as liquid biopsy to advance early cancer detection, enhance treatment monitoring, and enable personalized medicine approaches. A liquid biopsy is a non-invasive procedure that examines blood or other bodily fluids to find cancer cells or genetic material derived from tumors. For example, in November 2023, Guardant Health, Inc., a US-based biotechnology firm, launched its Shield blood-based screening tests. The Shield test analyzes cell-free DNA (cfDNA) present in the bloodstream, which can indicate the presence of colorectal tumors or precancerous formations. It specifically identifies modifications in DNA fragments that are released into the blood from cancer cells.

Which Global Market Leaders Are Shaping The Future Of The Blood Screening Sector?

Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

What Are The Key Regional Factors Influencing The Blood Screening Market Growth?

North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Blood Screening Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9047&type=smp

Browse Through More Reports Similar to the Global Blood Screening Market 2025, By The Business Research Company

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Blood And Blood Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795